Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Martin

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|March 1, 1984
(+/-)-4-Aryl-4,5-dihydro-3H-1,3-benzodiazepines. 3. 2-Phenyl and 2-amino analogues as potential antihypertensive agentsL L Setescak, F W Dekow, J M Kitzen, et al.
Journal of Medicinal Chemistry|March 1, 1984
Dibenz[b,e]oxepinalkanoic acids as nonsteroidal antiinflammatory agents. 4. Synthesis and evaluation of 4-(4,10-dihydro-10-oxothieno[3,2-c] [1]benzoxepin-8-yl)butanol and -butyric acid and related derivativesL L Martin, L L Setescak, T C Spaulding, et al.
Journal of Biochemistry|March 1, 1992
Identification and partial purification of a thiol endothelin-converting enzyme from porcine aortic endothelial cellsY Deng, P Savage, S S Shetty, et al.
Journal of Neurochemistry|April 1, 1990
Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the ratT S Rao, H S Kim, J Lehmann, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|November 5, 2002
The influence of promoter and of electrode material on the cyclic voltammetry of Pisum sativum plastocyaninD L Johnson, C J Maxwell, D Losic, et al.
Life Sciences|January 1, 1989
Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivoT S Rao, H S Kim, J Lehmann, et al.
Biochemistry International|September 1, 1992
Decrease in immunoreactivity and vasoactivity of endothelin-1 after exposure to oxygenJ L Balwierczak, M F Hopkins, P Savage, et al.
Neuropharmacology|March 1, 1990
Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptorsT S Rao, H S Kim, J Lehmann, et al.
Biochemical Pharmacology|April 29, 2005
Electrochemical characterisation of the human cytochrome P450 CYP2C9D L Johnson, B C Lewis, D J Elliot, et al.
Nursing Management|June 1, 1989
Clustering: decentralization and resource sharingJ N Ouellette, L L Martin, R B Holmes, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|March 1, 1984
(+/-)-4-Aryl-4,5-dihydro-3H-1,3-benzodiazepines. 3. 2-Phenyl and 2-amino analogues as potential antihypertensive agentsL L Setescak, F W Dekow, J M Kitzen, et al.
Journal of Medicinal Chemistry|March 1, 1984
Dibenz[b,e]oxepinalkanoic acids as nonsteroidal antiinflammatory agents. 4. Synthesis and evaluation of 4-(4,10-dihydro-10-oxothieno[3,2-c] [1]benzoxepin-8-yl)butanol and -butyric acid and related derivativesL L Martin, L L Setescak, T C Spaulding, et al.
Journal of Biochemistry|March 1, 1992
Identification and partial purification of a thiol endothelin-converting enzyme from porcine aortic endothelial cellsY Deng, P Savage, S S Shetty, et al.
Journal of Neurochemistry|April 1, 1990
Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the ratT S Rao, H S Kim, J Lehmann, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|November 5, 2002
The influence of promoter and of electrode material on the cyclic voltammetry of Pisum sativum plastocyaninD L Johnson, C J Maxwell, D Losic, et al.
Life Sciences|January 1, 1989
Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivoT S Rao, H S Kim, J Lehmann, et al.
Biochemistry International|September 1, 1992
Decrease in immunoreactivity and vasoactivity of endothelin-1 after exposure to oxygenJ L Balwierczak, M F Hopkins, P Savage, et al.
Neuropharmacology|March 1, 1990
Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptorsT S Rao, H S Kim, J Lehmann, et al.
Biochemical Pharmacology|April 29, 2005
Electrochemical characterisation of the human cytochrome P450 CYP2C9D L Johnson, B C Lewis, D J Elliot, et al.
Nursing Management|June 1, 1989
Clustering: decentralization and resource sharingJ N Ouellette, L L Martin, R B Holmes, et al.
Pageof 7